ATE109007T1 - Zellfreies marekskrankheitvirus-vakzin. - Google Patents

Zellfreies marekskrankheitvirus-vakzin.

Info

Publication number
ATE109007T1
ATE109007T1 AT91203365T AT91203365T ATE109007T1 AT E109007 T1 ATE109007 T1 AT E109007T1 AT 91203365 T AT91203365 T AT 91203365T AT 91203365 T AT91203365 T AT 91203365T AT E109007 T1 ATE109007 T1 AT E109007T1
Authority
AT
Austria
Prior art keywords
disease virus
cell
marek
virus vaccine
vaccine
Prior art date
Application number
AT91203365T
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE109007(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE109007T1 publication Critical patent/ATE109007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91203365T 1990-12-24 1991-12-20 Zellfreies marekskrankheitvirus-vakzin. ATE109007T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
ATE109007T1 true ATE109007T1 (de) 1994-08-15

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91203365T ATE109007T1 (de) 1990-12-24 1991-12-20 Zellfreies marekskrankheitvirus-vakzin.

Country Status (17)

Country Link
US (1) US5378467A (de)
EP (1) EP0496135B1 (de)
JP (1) JP3410744B2 (de)
KR (1) KR100187317B1 (de)
CN (1) CN1034554C (de)
AT (1) ATE109007T1 (de)
CA (1) CA2058386C (de)
DE (1) DE69103130T2 (de)
DK (1) DK0496135T3 (de)
DZ (1) DZ1550A1 (de)
ES (1) ES2061165T3 (de)
HU (2) HUT62200A (de)
IL (1) IL100386A (de)
MX (1) MX9102757A (de)
NZ (1) NZ241122A (de)
SA (1) SA92120430B1 (de)
ZA (1) ZA9110022B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (de) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Virusimpfstoff gegen Mareksche Krankheit
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
DK2384761T3 (da) * 2010-05-07 2013-12-09 Deutsches Krebsforsch Modificeret gnaverparvovirus, som er i stand til formering og spredning i humane gliomer
WO2019121888A1 (en) 2017-12-20 2019-06-27 Intervet International B.V. Improved diluent for cell-associated alphaherpesvirus vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
IL100386A (en) 1995-07-31
EP0496135A2 (de) 1992-07-29
CN1064409A (zh) 1992-09-16
CA2058386C (en) 2003-02-11
JP3410744B2 (ja) 2003-05-26
HUT62200A (en) 1993-04-28
DZ1550A1 (fr) 2002-02-17
EP0496135B1 (de) 1994-07-27
KR100187317B1 (ko) 1999-05-01
KR920011520A (ko) 1992-07-24
MX9102757A (es) 1992-07-01
EP0496135A3 (de) 1992-08-05
ES2061165T3 (es) 1994-12-01
CN1034554C (zh) 1997-04-16
DE69103130T2 (de) 1994-12-01
HU210344A9 (en) 1995-04-28
ZA9110022B (en) 1992-10-28
IL100386A0 (en) 1992-09-06
HU914111D0 (en) 1992-03-30
DK0496135T3 (da) 1994-11-28
CA2058386A1 (en) 1992-06-25
NZ241122A (en) 1992-10-28
SA92120430B1 (ar) 2004-05-31
JPH04295433A (ja) 1992-10-20
DE69103130D1 (de) 1994-09-01
US5378467A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
MY103575A (en) Cannie coronavirus vaccine
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
FI890116A0 (fi) Icke-reverterande rna-virus.
GR3007856T3 (de)
MX9602256A (es) Vacuna contra la enfermedad de marek.
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
ATE165620T1 (de) Impfstoffe auf basis geänderter boviner herpesviren typ 1
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
DE3269188D1 (en) Vaccine for hepatitis
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Baxendale Marek's disease virus vaccine
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
Wargo Interaction of stress and secondary organisms in decline of forest trees.
Bexendale Cell-free Marek's Disease virus vaccine
Honda et al. Live vaccine for contagious diseases of chickens.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
Von Ohlinger et al. Boar vaccination against Aujeszky's disease. 2. Communication: Virus excretion in nasal secretions and semen.
Lane Canine vaccination policy.
FI843163A7 (fi) Rokotteita ja koostumuksia hepatitis-B- virusinfektioita vastaan.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked